Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-26 @ 11:14 PM
Study NCT ID:
NCT02974803
Status:
TERMINATED
Last Update Posted:
2021-08-20
First Post:
2016-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
Sponsor:
Canadian Cancer Trials Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
I224
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |